---
title: "Atomoxetine - Attention Deficit Hyperactivity Disorder"
sidebar: mydoc_sidebar
permalink: db00289-mesh-d001289-1.html
toc: false 
---


Path ID: `DB00289_MESH_D001289_1`
{% include image.html url="images/db00289-mesh-d001289-1.png" file="db00289-mesh-d001289-1.png" alt="db00289-mesh-d001289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000069445">MESH:D000069445 </a> | Atomoxetine | Drug |
| <a href="https://identifiers.org/UniProt:P23975">UniProt:P23975 </a> | Sodium-dependent noradrenaline transporter | Protein |
| <a href="https://identifiers.org/GO:0004972">GO:0004972 </a> | NMDA glutamate receptor activity | MolecularActivity |
| <a href="https://identifiers.org/GO:0061527">GO:0061527 </a> | Dopamine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/GO:0051620">GO:0051620 </a> | Noradrenaline uptake | BiologicalProcess |
| <a href="https://identifiers.org/GO:0061535">GO:0061535 </a> | Glutamate secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Noradrenaline | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0061533">GO:0061533 </a> | Norepinephrine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D001289">MESH:D001289 </a> | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Atomoxetine | DECREASES ACTIVITY OF | Sodium-Dependent Noradrenaline Transporter |
| Atomoxetine | DECREASES ACTIVITY OF | Nmda Glutamate Receptor Activity |
| Atomoxetine | POSITIVELY REGULATES | Dopamine Secretion, Neurotransmission |
| Sodium-Dependent Noradrenaline Transporter | PARTICIPATES IN | Noradrenaline Uptake |
| Nmda Glutamate Receptor Activity | PARTICIPATES IN | Glutamate Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | NEGATIVELY CORRELATED WITH | Attention Deficit Hyperactivity Disorder |
| Noradrenaline Uptake | DECREASES ABUNDANCE OF | Noradrenaline |
| Glutamate Secretion, Neurotransmission | CORRELATED WITH | Attention Deficit Hyperactivity Disorder |
| Noradrenaline | PARTICIPATES IN | Norepinephrine Secretion, Neurotransmission |
| Norepinephrine Secretion, Neurotransmission | NEGATIVELY CORRELATED WITH | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00289](https://go.drugbank.com/drugs/DB00289)
  - [https://pubmed.ncbi.nlm.nih.gov/24259638/](https://pubmed.ncbi.nlm.nih.gov/24259638/)
